Pancreatic Cancer Research

ResearcherUniversity of California, Los AngelesActive in the last 2 years

Michael A. Mederos

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8098-7746; OpenAlex author ID A5007679975. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
24
Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: 1 paper

Papers 4

  1. Neoadjuvant chemotherapy is associated with improved disease-free survival in pancreatic cancer patients undergoing pancreaticoduodenectomy with vascular resec… Co-author DOI 10.1002/jso.27674↗
  2. Calling Out Disparities in Pancreatic Cancer Care. Co-author DOI 10.1001/jamasurg.2022.6720↗
  3. Pathological treatment response has different prognostic implications for pancreatic cancer patients treated with neoadjuvant chemotherapy or chemoradiotherapy. First author DOI 10.1016/j.surg.2021.10.015↗
  4. Poorly differentiated histologic grade correlates with worse survival in SMAD4 negative pancreatic adenocarcinoma patients. Co-author DOI 10.1002/jso.26279↗

Closest collaborators

The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Oscar Joe Hines · 3 shared papers, 2021–2023 · strength 0.63
  2. Timothy R. Donahue · 3 shared papers, 2021–2024 · strength 0.47
  3. Joon Y. Park · 3 shared papers, 2021–2024 · strength 0.47
  4. Mark D. Girgis · 3 shared papers, 2021–2024 · strength 0.47
  5. Jonathan C. King · 2 shared papers, 2021–2024 · strength 0.36
  6. Zev A. Wainberg · 2 shared papers, 2021–2022 · strength 0.25
  7. Dustin L. Dillon · 1 shared paper, 2024 · strength 0.23
  8. Howard A. Reber · 1 shared paper, 2021 · strength 0.13
  9. Hanlin L. Wang · 1 shared paper, 2021 · strength 0.13
  10. David W. Dawson · 1 shared paper, 2021 · strength 0.13
  11. Carlos F. Fernandez-del Castillo · 1 shared paper, 2022 · strength 0.12
  12. Jin Peng He · 1 shared paper, 2022 · strength 0.12
  13. Shimpei Maeda · 1 shared paper, 2022 · strength 0.12
  14. Lingdi Yin · 1 shared paper, 2022 · strength 0.12
  15. William R. Burns · 1 shared paper, 2022 · strength 0.12
  16. Sami Shoucair · 1 shared paper, 2022 · strength 0.12
  17. Alexandra M. Moore · 1 shared paper, 2022 · strength 0.12
  18. Richard Andrew Burkhart · 1 shared paper, 2022 · strength 0.12
  19. Jun Yu · 1 shared paper, 2022 · strength 0.12
  20. Christopher L. Wolfgang · 1 shared paper, 2022 · strength 0.12
  21. Motaz Qadan · 1 shared paper, 2022 · strength 0.12
  22. Cristina Rosa Ferrone · 1 shared paper, 2022 · strength 0.12
  23. Keith D. Lillemoe · 1 shared paper, 2022 · strength 0.12
  24. Akhil Chawla · 1 shared paper, 2022 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.